Literature DB >> 10703946

Anti-intercellular substance antibody log titres are correlated with serum concentrations of interleukin-6, interleukin-15 and tumor necrosis factor-alpha in patients with Pemphigus vulgaris relationships with peripheral blood neutrophil counts, disease severity and duration and patients' age.

F Ameglio1, L D'Auria, P Cordiali-Fei, E Trento, G D'Agosto, A Mastroianni, A Giannetti, B Giacalone.   

Abstract

Pemphigus vulgaris is a rare dermatosis of autoimmune origin, characterized by autoantibodies directed against intercellular substance (AICS) and presenting with intra-epidermal blisters and/or erosions of the skin and mucous membranes. The aim of this paper is to analyze the relationships between serum AICS titers (after log transformation) and: patients' age, disease duration and disease activity; serum cytokine (IL-6, IL-7, IL-15 and TNF-alpha) concentrations and peripheral blood cell counts (namely neutrophils, lymphocytes and natural killer cells). Fifteen consecutive subjects affected with PV were enrolled. Diagnosis was supported by histological examination as well as by direct and indirect immunofluorescence tests. Cytokine determinations were made by means of commercially available ELISA kits. This study shows for the first time that AICS titers have a significant correlation with age of PV patients (R=0.57, p=0.031) and with the disease duration (R=0.73, p=0.002). A correlation between blood neutrophils count and log (AICS) titres was observed (R=0.6, p=0.021). Furthermore, significant correlations were observed between log (AICS) titres and serum IL-15 (R=0.54, p=0.048), serum IL-6 (R=0.53, p=0.05) or serum TNF-alpha concentrations (R=0.53, p=0.05). These data, taken together, show that there are several connections between the log (AICS) titres, some proinflammatory cytokines, peripheral blood neutrophil counts and the numbers of individuals' lesions, suggesting a relationship between AICS production and lesion development.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10703946

Source DB:  PubMed          Journal:  J Biol Regul Homeost Agents        ISSN: 0393-974X            Impact factor:   1.711


  10 in total

Review 1.  Pemphigus: a Comprehensive Review on Pathogenesis, Clinical Presentation and Novel Therapeutic Approaches.

Authors:  Robert Pollmann; Thomas Schmidt; Rüdiger Eming; Michael Hertl
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

2.  Novel mechanisms of target cell death and survival and of therapeutic action of IVIg in Pemphigus.

Authors:  Juan Arredondo; Alexander I Chernyavsky; Ali Karaouni; Sergei A Grando
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

3.  A multicentre randomized trial of the treatment of patients with pemphigus vulgaris with infliximab and prednisone compared with prednisone alone.

Authors:  R P Hall; J Fairley; D Woodley; V P Werth; D Hannah; R D Streilein; J McKillip; J Okawa; M Rose; L L Keyes-Elstein; A Pinckney; A Overington; J Wedgwood; L Ding; B Welch
Journal:  Br J Dermatol       Date:  2015-02-05       Impact factor: 9.302

4.  Antimitochondrial autoantibodies in pemphigus vulgaris: a missing link in disease pathophysiology.

Authors:  Steve Marchenko; Alexander I Chernyavsky; Juan Arredondo; Vivian Gindi; Sergei A Grando
Journal:  J Biol Chem       Date:  2009-12-10       Impact factor: 5.157

5.  Evaluation of recombinant antigen-based assays for diagnosis of bullous autoimmune diseases.

Authors:  G D'Agosto; A Latini; M Carducci; A Mastroianni; A Vento; P Cordiali Fei
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

Review 6.  Pemphigus autoimmunity: hypotheses and realities.

Authors:  Sergei A Grando
Journal:  Autoimmunity       Date:  2011-09-23       Impact factor: 2.815

7.  Th1/Th17-Related Cytokines and Chemokines and Their Implications in the Pathogenesis of Pemphigus Vulgaris.

Authors:  Rodolfo Pessato Timoteo; Marcos Vinicius da Silva; Camila Botelho Miguel; Djalma Alexandre Alves Silva; Jonatas Da Silva Catarino; Virmondes Rodrigues Junior; Helioswilton Sales-Campos; Carlo Jose Freire Oliveira
Journal:  Mediators Inflamm       Date:  2017-02-22       Impact factor: 4.711

8.  Elevated Serum Levels of Interleukin-15 in Pemphigus Vulgaris Patients: a Potential Therapeutic Target.

Authors:  Maedeh Kheirodin; Zohreh Tehranchinia; Yasaman Ketabi; Soheil Tavakolpour; Sahar Dadkhahfar; Masoomeh Faghankhani; Hassan Vahidnezhad; Nikoo Mozafari
Journal:  Dermatol Pract Concept       Date:  2022-07-01

9.  Expression of JAK3, STAT2, STAT4, and STAT6 in pemphigus vulgaris.

Authors:  K Juczynska; A Wozniacka; E Waszczykowska; M Danilewicz; M Wągrowska-Danilewicz; Agnieszka Zebrowska
Journal:  Immunol Res       Date:  2020-04       Impact factor: 2.829

Review 10.  Marked to Die-Cell Death Mechanisms for Keratinocyte Acantholysis in Pemphigus Diseases.

Authors:  Valéria Bumiller-Bini Hoch; Larissa Schneider; Anna Elisabeth Pumpe; Emelie Lüders; Jennifer Elisabeth Hundt; Angelica Beate Winter Boldt
Journal:  Life (Basel)       Date:  2022-02-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.